Maddyness Q&A with Noel McKenna of Neuranics - The ultimate wearable for biomagnetic sensing

What a great way to start off the year seeing our portfolio company Neuranics feature in Maddyness - an in-depth Q&A with CEO Noel McKenna exploring the business, its progress towards transforming the digital health industry and Noel’s advice to other founders. 

Neuranics is at the forefront of the biomedical industry, developing cutting-edge wearables, reshaping the way individuals engage with computers and digital experiences. 

This innovative technology surpasses existing constraints in health monitoring and human-machine interfaces, and is cost-effective, scalable, and uses minimal power consumption.

This also coincides with a very successful trip to CES last week for Neuranics and also another Par portfolio company, novosound. Taking cutting edge health tech innovation in Scotland to the global stage.

https://bit.ly/3tVeV6J